Socioeconomic inequalities and cardiovascular disease in Sweden
In her thesis, Ninoa Malki concludes that socioeconomic differences are associated with both incidence and mortality of cardiovascular disease in Sweden.
In her thesis, Ninoa Malki concludes that socioeconomic differences in both incidence and prognosis of cardiovascular disease (CVD) have been stable over time in Sweden and that social gradient exist both in subclinical biomarkers for atherosclerosis and in prescription of CVD preventive drugs.
CVD accounts for 30% of global mortality and is the most common cause of death in the world although population-wide prevention strategies and healthcare interventions have led to a decrease in incidence and mortality. Socioeconomic position (SEP) is associated with almost the entire developmental course of CVD, from modifiable risk factors and atherosclerosis to incidence, survival, and mortality.
Ninoa wanted to investigate how absolute and relative SEP inequalities in myocardial infarction and ischemic stroke have developed over time in Sweden, and additionally, to investigate the association between SEP and subclinical biomarkers for atherosclerosis, as well as with prescription of CVD preventive drugs.
In Sweden, everyone should have access to preventive drugs for CVD regardless of socioeconomic status, but that is not the case today.
On March 13, Ninoa will defend her thesis "Epidemiological studies on socioeconomic inequalities and cardiovascular disease: prevention, progression and prognosis".
Ninoa’s opponent is Adjunct Professor Scott Montgomery, Department of School of Medical Sciences at Örebro University. Her supervisors are Pär Sparén, Alexander Ploner, Sara Hägg and Ilona Koupil.
Location: Lecture hall Petrén, Nobels väg 12B, Karolinska Institutet, Solna
Read the thesis in KI's open archive.